Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Nuveen New York Quality Municipal Income Fund
NAN
$369M
| $190K | ﹤0.01% |
17,797
-91
| -0.5% | -$945 |
|
|
HIX
3652
Western Asset High Income Fund II
HIX
$347M
| $189K | ﹤0.01% |
39,053
-27,817
| -42% | -$134K |
|
3653
Nomura Holdings
NMR
$28.3B
| $186K | ﹤0.01% |
49,371
-36,350
| -42% | -$126K |
|
3654
Alto Ingredients
ALTO
$338M
| $185K | ﹤0.01% |
+64,235
| New | +$228K |
|
3655
Kodiak Sciences
KOD
$2.5B
| $185K | ﹤0.01% |
25,757
+10,774
| +72% | +$77.3K |
|
3656
Theravance Biopharma
TBPH
$873M
| $185K | ﹤0.01% |
+16,430
| New | +$173K |
|
3657
Compañía de Minas Buenaventura
BVN
$7.68B
| $182K | ﹤0.01% |
24,423
+1,061
| +5% | +$7.86K |
|
|
FAX
3658
abrdn Asia-Pacific Income Fund
FAX
$592M
| $182K | ﹤0.01% |
11,542
-24,051
| -68% | -$362K |
|
|
HYB
3659
DELISTED
New America High Income Fund, Inc.
HYB
| $179K | ﹤0.01% |
27,134
-400
| -1% | -$2.69K |
|
|
ENLC
3660
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $178K | ﹤0.01% |
14,413
| – | – |
|
|
BKN
3661
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $177K | ﹤0.01% |
17,217
-9,254
| -35% | -$110K |
|
3662
Matrix Service
MTRX
$312M
| $176K | ﹤0.01% |
28,300
-76,300
| -73% | -$394K |
|
3663
OmniAb
OABI
$283M
| $176K | ﹤0.01% |
+48,637
| New | +$255K |
|
3664
Sana Biotechnology
SANA
$882M
| $175K | ﹤0.01% |
44,292
+459
| +1% | +$2.25K |
|
3665
UNIFI
UFI
$114M
| $173K | ﹤0.01% |
20,125
-39,584
| -66% | -$340K |
|
3666
Amneal Pharmaceuticals
AMRX
$6.1B
| $172K | ﹤0.01% |
86,305
+26,851
| +45% | +$60.2K |
|
|
MUE
3667
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
| $171K | ﹤0.01% |
+18,138
| New | +$180K |
|
3668
Star Group
SGU
$413M
| $169K | ﹤0.01% |
13,995
| – | – |
|
3669
Cardlytics
CDLX
$22.2M
| $166K | ﹤0.01% |
+2,867
| New | +$177K |
|
|
GOGL
3670
DELISTED
Golden Ocean Group
GOGL
| $166K | ﹤0.01% |
19,079
-109,882
| -85% | -$955K |
|
3671
Grab
GRAB
$13.7B
| $166K | ﹤0.01% |
51,602
+5,603
| +12% | +$16.1K |
|
|
BTA
3672
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $164K | ﹤0.01% |
+18,424
| New | +$172K |
|
3673
Escalade
ESCA
$271M
| $164K | ﹤0.01% |
16,143
+287
| +2% | +$2.98K |
|
3674
Gold Fields
GFI
$28.8B
| $164K | ﹤0.01% |
15,836
+4,528
| +40% | +$43.9K |
|
3675
ADT
ADT
$5.43B
| $162K | ﹤0.01% |
17,891
-2,132
| -11% | -$19K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.